基础医学院

联系方式

地址:泸州市龙马潭区香林路1段1号
邮编:646000
单位:西南医科大学基础医学院
电话:0830-3160073

当前位置: 网站首页 > 师资队伍 > 导师风采 > 正文

易婧妍

发布时间:2024-11-05 08:38:03 点击率: 字体大小:

易婧妍,理学博士,女,1993年12月出生。西南医科大学基础医学院医学细胞生物学与遗传学教研室,副教授,硕士研究生导师,教育部医学电生理重点实验室/四川省医学电生理重点实验室博士后。获得西南医科大学优秀兼职班主任,西南医科大学基础医学院教育教学突出贡献奖等荣誉。近年来主持国家自然科学基金1项,中国博士后科学基金1项,厅局级课题1项;在EBioMedicine Clinical Science等国际期刊发表论文17篇;授权国家发明专利1项。

1. 学习及工作经历

2011.09-2015.06,山东大学,生物科学,学士

2015.09-2020.06,大连医科大学,生物化学与分子生物学,博士

2020.07-2023.12,西南医科大学,基础医学院,讲师

2022.05-至今,西南医科大学,心血管医学研究所,博士后

2023.10-至今,西南医科大学,代谢性心血管疾病医药基础研究创新中心,主任助理

2023.12-至今,西南医科大学,基础医学院,副教授

2. 联系方式

邮箱:jingyany@swmu.edu.cn

3. 研究方向:

(1)女性生殖系统疾病:妇科肿瘤诊治、生殖内分泌疾病发病机制的研究

(2)心血管疾病:心血管疾病及心血管药理学方面的研究

4. 承担项目:

(1)国家自然科学基金青年项目,2024.01-2026.12,主持

(2)中国博士后科学基金面上项目,2023.01-2024.12,主持

(3)泸州市科学技术和人才工作局,2023.07-2025.07,主持

5. 代表性论文:

(1) Jingyan Yi#; Chongya Liu#; Zhiwei Tao; Min Wang; Yaxun Jia; Xiaolin Sang; Lanlin Shen; Yijue Xue; Kui Jiang; Fuwen Luo; Pixu Liu*; Hailing Cheng*; MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer, EBioMedicine, 2019, 43: 225-237

(2) Jinshan Xing; Jingyan Yi*; Comprehensive analysis of LASS6 expression and prognostic value in ovarian cancer, Journal of Ovarian Research, 2021, 14(1): 117

(3) Jinshan Xing#; Jun Yang; Yingjiang Gu*; Jingyan Yi*; Research update on the anticancer effects of buparlisib (Review), Oncology Letters, 2021, 21(4): 266

(4) Gan Qiao#; Jinshan Xing#; Xin Luo#; Chunxiang Zhang*; Jingyan Yi*; Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome, Endocrine, 2022 78(3):615-627

(5) Xin Luo#; Jinshan Xing#; Yingjiang Gu; Gan Qiao; Minghua Liu; Jingyan Yi*; Network Pharmacology Analysis and Experimental Pharmacology Study Explore the Mechanism of Asparagus against Glioblastoma. Journal of Food Biochemistry. 2023; 2023 1-11.

(6) Jinshan Xing#; Gan Qiao#; Xin Luo#; Shuang Liu; Shaokun Chen; Geng Ye; Chunxiang Zhang*; Jingyan Yi*; Ferredoxin 1 regulates granulosa cell apoptosis and autophagy in polycystic ovary syndrome, Clinical Science, 2023, 137(6): 453-468.

(7) Jingyan Yi#; Xin Luo#; Jinshan Xing; Aharon Gedanken; Xiukun Lin; Chunxiang Zhang*; Gan Qiao*; Micelle encapsulation zinc‐doped copper oxide nanocomposites reverse Olaparib resistance in ovarian cancer by disrupting homologous recombination repair, Bioengineering & Translational Medicine, 2023, 8(3): e10507

(8) Jinshan Xing#; Xin Luo#; Keran Jia; Shuang Liu; Shaokun Chen; Gan Qiao; Chunxiang Zhang*; Jingyan Yi*; Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of asparagus against polycystic ovary syndrome, Journal of Ovarian Research, 2023, 16(1): 128.

(9) Xin Luo#; Keran Jia; Jinshan Xing*; Jingyan Yi*; The utilization of nanotechnology in the female reproductive system and related disorders. Heliyon. 2024; 10 (3): e25477.

(10) Keran Jia#; Xin Luo#; Jingyan Yi*; Chunxiang Zhang*. Hormonal influence: unraveling the impact of sex hormones on vascular smooth muscle cells. Biological Research. 2024; 57 (1): 61.

Apycom